Inmune Stock Market Sentiment


USD 10.39  0.08  0.78%   

Inmune investor sentiment overview provides quick insight into current market opportunities from investing in Inmune Bio. The current market sentiment together Inmune Bio's historical and current headlines can help investors to time the market. Many technical investors use Inmune Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Inmune Bio Hype Analysis, Inmune Bio Correlation and Inmune Bio Performance.
Inmune Bio stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Inmune daily returns and investor perception about the current pice of Inmune Bio as well as its diversification or hedging effects on your existing portfolios.

Inmune Historical Sentiment

Although Inmune Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Inmune, such as negative comments on social media and news outlets, may cause fear in the market and push Inmune Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Inmune.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Inmune Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Inmune Bio.

Inmune Bio Sentiment by News Outlets

fool News
Macroaxis News:
zacks News
benzinga news

Inmune Bio Historical Investor Sentiment

Investor biases related to Inmune Bio's public news can be used to forecast risks associated with investment in Inmune. The trend in average sentiment can be used to explain how an investor holding Inmune can time the market purely based on public headlines and social activities around Inmune Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Inmune Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Inmune Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Inmune Bio's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Inmune Bio.

Inmune Bio Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Inmune Bio has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Inmune Bio's prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Inmune Bio. Our Twitter sentiment analysis of Inmune Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
few days ago at         
Is Sonos, Inc.s Latest Stock Performance A Reflection Of Its Financial Health - Nasdaq
nasdaq News
over a week ago at         
Form 8-K Inmune Bio, Inc. For Jul 27 -
Street Insider News
over a week ago at         
INmune Bio Alzheimers Association International Conference Systems Biology of Alzheimers Disease Pan...
Macroaxis News:
over two weeks ago at         
INmune Bio May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - Yahoo Fina...
Yahoo News
over three weeks ago at         
Annovis Bio to Present at the Alzheimers Association International Conference -
Macroaxis News:
over three weeks ago at         
Heres Why INmune Bio Can Manage Its Debt Despite Losing Money - Simply Wall St
Simply Wall St News at Macroaxis
over a month ago at         
INmune Bio USPTO Issues Patent Covering Use of XPro for Treatment of CNS Diseases - Form 8-K - Marke...
Macroaxis News:
over a month ago at         
ACIU stock leads selloff in Alzheimers space after trial setback - Seeking Alpha
seekingalpha News
over a month ago at         
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of INmune Bio, Inc. ...
benzinga news
over a month ago at         
Will INmune Bio Inc Stay at the Top of the Healthcare Sector - InvestorsObserver
Investors Business Daily at Macroaxis
over two months ago at         
Can INmune Bio, Inc. Climb 105 percent to Reach the Level Wall Street Analysts Expect - Yahoo Financ...
Yahoo News
over two months ago at         
David Moss Is The CFO, Treasurer Secretary of INmune Bio, Inc. And Just Spent US69k On Shares - Simp...
Simply Wall St News at Macroaxis
over two months ago at         
CFO, Treasurer Secretary David Moss Just Bought A Handful Of Shares In INmune Bio, Inc. - Yahoo Movi...
Yahoo News
over two months ago at         
Purchase by Tesi Raymond Joseph of 6300 shares of Inmune Bio
Macroaxis News
over two months ago at         
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of INmune Bio, Inc. ...
benzinga news
Far too much social signal, news, headlines, and media speculation about Inmune Bio that are available to investors today. That information is available publicly through Inmune media outlets and privately through word of mouth or via Inmune internal channels. However, regardless of the origin, that massive amount of Inmune data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inmune Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inmune Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inmune Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inmune Bio alpha.

Inmune Bio Performance against DOW

 Price Growth (%)  
INmune Bio, Inc. to Present at the H.C. Wainwright Global Hy...05/17/2022
Financial Statements05/18/2022
Financial Statements05/23/2022
Financial Statements05/24/2022
INmune Bio Shares Rebound From 52-Week Low, Up 9 percent - M...05/25/2022
Purchase by Tesi Raymond Joseph of 6300 shares of Inmune Bio05/31/2022
CFO, Treasurer Secretary David Moss Just Bought A Handful Of...06/02/2022
Will INmune Bio Inc Stay at the Top of the Healthcare Sector...06/09/2022
Financial Statements06/16/2022
INmune Bio USPTO Issues Patent Covering Use of XPro for Trea...06/23/2022
EPS Estimate06/30/2022
Financial Statements07/25/2022
Financial Statements07/27/2022
Is Sonos, Inc.s Latest Stock Performance A Reflection Of Its...08/01/2022
EPS Reported08/03/2022
Please see Inmune Bio Hype Analysis, Inmune Bio Correlation and Inmune Bio Performance. Note that the Inmune Bio information on this page should be used as a complementary analysis to other Inmune Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Inmune Stock analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
186.5 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.